Moderna

MRNA

Market cap $24.9B

MRNA Hedge Fund Activity: Q1 2026 in Review

722 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in Moderna (MRNA) for Q1 2026, worth a combined $15.6B — up 74% from $9B a quarter earlier.

Buyers outnumbered sellers: 148 funds opened new MRNA positions and 82 closed out — a net gain of 66 holders — while 236 added to existing stakes and 200 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $822M. The largest seller was D.E. Shaw & Co, cutting an estimated $211M.

• 722 institutional investors held Moderna (MRNA) as of Q1 2026, up from 672 in Q4 2025.
• Funds reported $15.6B of Moderna stock for Q1 2026, up 74% quarter-over-quarter.
• 148 funds opened new Moderna positions in Q1 2026 and 82 closed out, a net change of +66 holders.
• The largest Moderna buyer in Q1 2026 was Fidelity Investments, an estimated $822M added.
• The largest Moderna seller in Q1 2026 was D.E. Shaw & Co, an estimated $211M sold.

Based on aggregated 13F filings for Q1 2026.